{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:25:36Z","timestamp":1793507136810,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC3503205"],"award-info":[{"award-number":["2023YFC3503205"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["SZSM202311002"],"award-info":[{"award-number":["SZSM202311002"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472658"],"award-info":[{"award-number":["82472658"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.canlet.2026.218548","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:48:58Z","timestamp":1777520938000},"page":"218548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Lactylation of HIF-1\u03b1 at K172 drives HIF-1 complex assembly to promote hypoxia-induced immune evasion in esophageal squamous cell carcinoma"],"prefix":"10.1016","volume":"651","author":[{"given":"Ji","family":"Cong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4242-033X","authenticated-orcid":false,"given":"Zhihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218548_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218548_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","article-title":"Epidemiology of esophageal squamous cell carcinoma","volume":"154","author":"Abnet","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218548_bib3","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(24)02226-8","article-title":"Oesophageal cancer","volume":"404","author":"Yang","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218548_bib4","first-page":"21","article-title":"Patterns and trends in esophageal cancer incidence and mortality in China: an analysis based on cancer registry data","volume":"3","author":"Chen","year":"2023","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.canlet.2026.218548_bib5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jtcvs.2020.11.106","article-title":"Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer","volume":"161","author":"Sihag","year":"2021","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.canlet.2026.218548_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ijc.33976","article-title":"Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): a multicenter, phase 2 study","volume":"151","author":"Liu","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218548_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004291","article-title":"Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma","volume":"10","author":"Liu","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218548_bib8","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1038\/s41591-024-03064-w","article-title":"Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO\/NCCES01 trial","volume":"30","author":"Qin","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.canlet.2026.218548_bib9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41568-025-00872-1","article-title":"The immune microenvironment of colorectal cancer","volume":"25","author":"Kennel","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218548_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218548_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ccell.2025.01.007","article-title":"Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer","volume":"43","author":"Zhang","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218548_bib12","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.ccell.2023.09.011","article-title":"Progenitor-like exhausted SPRY1(+)CD8(+) T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218548_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218548_bib14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s42255-019-0045-8","article-title":"Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy","volume":"1","author":"Ye","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.canlet.2026.218548_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nrc2344","article-title":"Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability","volume":"8","author":"Bristow","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218548_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-019-1122-z","article-title":"Hypoxia induced LUCAT1\/PTBP1 axis modulates cancer cell viability and chemotherapy response","volume":"19","author":"Huan","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218548_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/j.gastro.2024.10.042","article-title":"Hypoxic and acidic tumor microenvironment-driven AVL9 promotes chemoresistance of pancreatic ductal adenocarcinoma via the AVL9-IkappaBalpha-SKP1 complex","volume":"168","author":"Ding","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218548_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semcancer.2023.11.006","article-title":"Tumor hypoxia and radiotherapy: a major driver of resistance even for novel radiotherapy modalities","volume":"98","author":"Beckers","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2026.218548_bib19","article-title":"Multifunctional graphdiyne-cerium oxide nanozymes facilitate MicroRNA delivery and attenuate tumor hypoxia for highly efficient radiotherapy of esophageal cancer","volume":"33","author":"Zhou","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.canlet.2026.218548_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41577-024-01087-5","article-title":"How oxygenation shapes immune responses: emerging roles for physioxia and pathological hypoxia","volume":"25","author":"Mirchandani","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218548_bib21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","article-title":"Metabolic barriers to cancer immunotherapy","volume":"21","author":"DePeaux","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218548_bib22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cmet.2022.12.005","article-title":"Metabolic adaptation supports enhanced macrophage efferocytosis in limited-oxygen environments","volume":"35","author":"Wang","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218548_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41590-022-01379-9","article-title":"Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity","volume":"24","author":"Vignali","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2026.218548_bib24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nrclinonc.2018.9","article-title":"Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa","volume":"15","author":"Khan","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218548_bib25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41571-025-01000-6","article-title":"Enhancing immunotherapy with tumour-responsive nanomaterials","volume":"22","author":"Linderman","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218548_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202200389","article-title":"Hybrid-membrane-decorated prussian blue for effective cancer immunotherapy via tumor-associated macrophages polarization and hypoxia relief","volume":"34","author":"Hou","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.canlet.2026.218548_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccell.2024.12.001","article-title":"Targeting P4HA1 promotes CD8(+) T cell progenitor expansion toward immune memory and systemic anti-tumor immunity","volume":"43","author":"Ma","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218548_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2026.218548_bib29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41576-020-0270-8","article-title":"The evolving metabolic landscape of chromatin biology and epigenetics","volume":"21","author":"Dai","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2026.218548_bib30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218548_bib31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218548_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218548_bib33","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.cell.2025.03.048","article-title":"Long-term histone lactylation connects metabolic and epigenetic rewiring in innate immune memory","volume":"188","author":"Ziogas","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218548_bib34","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1038\/s41590-024-01985-9","article-title":"Histone lactylation drives CD8(+) T cell metabolism and function","volume":"25","author":"Raychaudhuri","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2026.218548_bib35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","article-title":"Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma","volume":"57","author":"De Leo","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218548_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2022.12.004","article-title":"Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218548_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C","article-title":"Characterization of 21 newly established esophageal cancer cell lines","volume":"69","author":"Shimada","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2026.218548_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature20805","volume":"541","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218548_bib39","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218548_bib40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2026.218548_bib41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218548_bib42","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1038\/s41467-022-31764-9","article-title":"Hypoxia induces HIF1alpha-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy","volume":"13","author":"Ma","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218548_bib43","article-title":"Hypoxia studies with pimonidazole in vivo","volume":"4","author":"Aguilera","year":"2014","journal-title":"Bio Protoc"},{"key":"10.1016\/j.canlet.2026.218548_bib44","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218548_bib45","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrd1199","article-title":"HIF-1 as a target for drug development","volume":"2","author":"Giaccia","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2026.218548_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nature14883","article-title":"Structural integration in hypoxia-inducible factors","volume":"524","author":"Wu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218548_bib47","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.aad1172","article-title":"Structures of aminoarabinose transferase ArnT suggest a molecular basis for lipid A glycosylation","volume":"351","author":"Petrou","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218548_bib48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12964-025-02366-x","article-title":"Lactylation modification of HIF-1alpha enhances its stability by blocking VHL recognition","volume":"23","author":"Li","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.canlet.2026.218548_bib49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-019-1027-x","article-title":"Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity","volume":"18","author":"Li","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218548_bib50","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","article-title":"Enhancing CD8(+) T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy","volume":"32","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218548_bib51","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1038\/s41467-025-61560-0","article-title":"YY1 enhances HIF-1alpha stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218548_bib52","article-title":"ENO1 promotes PDAC progression by inhibiting CD8(+) T cell infiltration through upregulating PD-L1 expression via HIF-1alpha signaling","volume":"52","author":"Aziguli","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2026.218548_bib53","article-title":"Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218548_bib54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s13059-025-03845-7","article-title":"Lactate-binding protein DNMT3A in HRMECs promotes angiogenesis by upregulating VEGFA through HIF-1alpha lactylation","volume":"26","author":"Wang","year":"2025","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2026.218548_bib55","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.ijbiomac.2022.10.014","article-title":"HIF1alpha lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer","volume":"222","author":"Luo","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.canlet.2026.218548_bib56","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41590-025-02178-8","article-title":"Targeting lactylation reinforces NK cell cytotoxicity within the tumor microenvironment","volume":"26","author":"Jin","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2026.218548_bib57","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218548_bib58","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0092-8674(02)01085-1","article-title":"Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation","volume":"111","author":"Jeong","year":"2002","journal-title":"Cell"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:07:31Z","timestamp":1783141651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526003113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":58,"alternative-id":["S0304383526003113"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218548","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lactylation of HIF-1\u03b1 at K172 drives HIF-1 complex assembly to promote hypoxia-induced immune evasion in esophageal squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218548"}}